20G SMA LASER FIBER, MODEL LF100
K050807 · Ophthalmed, LLC · HQF · Sep 21, 2005 · Ophthalmic
Device Facts
| Record ID | K050807 |
| Device Name | 20G SMA LASER FIBER, MODEL LF100 |
| Applicant | Ophthalmed, LLC |
| Product Code | HQF · Ophthalmic |
| Decision Date | Sep 21, 2005 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 886.4390 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
For use to perform endo-ocular laser photocoagulation treatments, with illumination, aspiration and backwash during surgical interventions. The operating wavelength is 500 nm to 1,100 nm
Device Story
The LF100 is a 20G ophthalmic surgical probe combining laser delivery, illumination, and aspiration/back-wash capabilities. It features a handpiece with a 20G extension, an 8 ft fiberoptic cable, and connectors for laser and illumination sources, plus a Luer lock for connection to a vitrectomy machine. The device is used by ophthalmologists in a surgical setting to facilitate intraocular procedures. The laser fiber provides photocoagulation, the illumination fiber provides visualization of the surgical site, and the aspiration/back-wash tube allows for fluid management. By integrating these functions into a single probe, the device simplifies the surgical workflow, potentially reducing procedure time and improving surgical access within the eye.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
20G ophthalmic probe; includes fiberoptics for laser (500-1100 nm) and illumination, and a tube for aspiration/back-wash. Handpiece with 8 ft fiber length. Sterilized via Ethylene Oxide. No electrical, thermal, or radiation components integral to the probe function.
Indications for Use
Indicated for patients undergoing endo-ocular surgical interventions requiring laser photocoagulation, illumination, and fluid aspiration/back-wash.
Regulatory Classification
Identification
An ophthalmic laser is an AC-powered device intended to coagulate or cut tissue of the eye, orbit, or surrounding skin by a laser beam.
Predicate Devices
- 20g and 25g SMA Laser Fibers, Model LF20 and LF25 (K021696)
- K982462
- K946135
Related Devices
- K022228 — FAMILY OF IRIS MEDICAL ENDOPROBE HANDPIECES · Iridex Corp · Oct 8, 2002
- K191846 — MAXReach Laser Probe · Vortex Surgical, Inc. · Dec 23, 2019
- K121187 — KATALYST LASER PROBES, KATALYST ILLUMINATED LASER PROBES · Katalyst Surgical, LLC · Sep 17, 2012
- K140362 — KATALYST REVOLVER LASER PROBES, KATALYST REVOLVER ILLUMINATED LASER PROBES, KATALYST REVOLVER ILLUMINATED PROBES · Katalyst Surgical, LLC · Sep 15, 2014
- K061024 — PEREGRINE SOFT TIP ASPIRATING LASER PROBE, MODEL PD720.60 · Peregrine Surgical , Ltd. · Jun 21, 2006
Submission Summary (Full Text)
{0}------------------------------------------------
# SEP 2 1 2005
# K050807
# 510(k) Summary As Required by 21 section 807.92 ( c )
1-Submitter Name: OphthalMed LLC 1308 Morningside Park Dr 2-Address: Alpharetta, GA 30022 USA (678) 908- 8180 3-Phone: (678) 623- 3765 4-Fax: 5-Contact Person: Jay Mansour 6-Date summary prepared: July 14th, 2005
7-Device Trade or Proprietary Name: 20g SMA Laser/Illumination/Aspiration/Back-wash probes. Model LF100
8-Device Common or usual name: (1) Ophthalmic laser, (2) Endoillumination probe and (3) vitreous aspiration
(1) Ophthalmic laser, (2) Light, surgical, fiberoptic and 9-Device Classification Name: (3) Instrument, vitrous aspiration and cutting
10-Substantial Equivalency is claimed against the following device:
20g and 25g SMA Laser Fibers, Model LF20 and LF25 from OPHTHALMED LLC (510k #K021696), as well as 510k #K982462 and K946135.
### 11-Description of the Device:
This device consists of the following parts already connected to each other:
- Handpiece with a 20G extension that holds the tip of the fibers and tubes, and guides it inside the eye.
- 8 ft fiber.
- A special connector that attaches the laser fiberoptic end to the laser source.
- A special connector that attaches the illumination fiberoptic end to the illumination source
- Luer lock that attaches the aspiration/ back-wash tube to the vitrectomy machine
- A flexible plastic jacket covers the length of the fiberoptics and tubes.
Laser fiberoptic provides the function of laser photocoagulation treatment. Illumination fiberoptic (by providing illumination) provides the physician with the view at the surgical site, while aspiration/backwash tube allows suction of intraocular fluids at the surgical site to facilitate the laser photocoagulation.
#### 12-Intended use of the device:
For use to perform endo-ocular laser photocoagulation treatments, with illumination, aspiration and backwash during surgical interventions. The operating wavelength is 500 nm to 1,100 nm
### 13-Safety and Effectiveness of the device:
This device is safe and effective as the other predicate device cited above. This is better expressed in the tabulated comparison (Paragraph 14 below)
## 14-Summary comparing technological characteristics with other predicate device:
{1}------------------------------------------------
Please find below a tabulated comparison supporting that this device is substantially equivalent
and submit and the supportion distribution I fease find before a laes in commercial distribution.
| FDA file reference<br>number | TECHNOLOGICAL<br>CHARACTERISTICS | 510k #K021696 for<br>laser<br>Comparison result | 510k #K982462 for<br>illumination<br>Comparison result | 510k #K946135 for<br>aspiration/back-wash<br>Comparison result |
|--------------------------------------------------------|----------------------------------|-------------------------------------------------|--------------------------------------------------------|----------------------------------------------------------------|
| Indications for use | Identical | Identical | Identical | |
| Target population | Identical | Identical | Identical | |
| Design | Similar | Similar | Similar | |
| Materials | Similar | Similar | Similar | |
| Performance | Similar | Similar | Similar | |
| Sterility | Similar (Ethylene<br>Oxide) | Similar (Ethylene Oxide) | Similar (Ethylene Oxide) | |
| Biocompatibility | Similar | Identical | Identical | |
| Mechanical safety | Similar | Similar | Similar | |
| Chemical safety | Similar | Similar | Similar | |
| Anatomical sites | Identical | Identical | Identical | |
| Human factors | Identical | Identical | Identical | |
| Energy used and/or<br>delivered | Identical | Similar | Similar | |
| Compatibility with<br>environment and other<br>devices | Identical | Identical | Identical | |
| Where used | Identical | Identical | Identical | |
| Standards met | Identical | Identical | Identical | |
| Electrical safety | Identical (not<br>applicable) | Identical (not applicable) | Identical (not applicable) | |
| Thermal safety | Identical (not<br>applicable) | Identical (not applicable) | Identical (not applicable) | |
| Radiation safety | Identical (not<br>applicable) | Identical (not applicable) | Identical (not applicable) | |
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines forming its body and head. The logo is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
SEP 2 1 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OphthalMed LLC c/o Mr. Jay Mansour Director, QA and Regulatory Affairs 1308 Morningside Park Dr. Alpharetta, GA 30022
Re: K050807
KU50807
Trade/Device Name: OphthalMed 20G SMA Laser/Illumination/Aspiration/A Back-wash probe, Model LF100
Regulation Number: 21 CFR 886.4390 Regulation: Ophthalmic laser Regulatory Class: II Product Code: HQF Dated: August 31, 2005 Received: September 1, 2005
Dear Mr. Mansour:
We have reviewed your Section 510(k) premarket notification of intent to market the indication We have reviewed your Section 310(x) premaintly equivalent (for the indications
referenced above and have determined the device is substantially interstate referenced above and nave determined the arrested predicate devices marketed in interstate for use stated in the enclosure) to regally manced promotions of the Federal Food. Device American Food. Drug commerce prior to May 28, 1970, the charger with the provisions of the Federal Food, Drug, devices that have been reculted in accordance with as proval approval application (PMA).
and Cosmetic Act (Act) that do not require approval of a provisions of the Act. The and Cosmetic Act (Act) that do not require approvate of the general controls of the Act. The Act. The Act. The
You may, therefore, market the device, subject to the gener You may, therefore, market the device, subject to annual registration, listing of
general controls provisions of the Act include requirements michronding and general controls provisions of the net network of the measure misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (sec above) the existing major regulations affecting your device and may be subject to such additional controlls. Existing may of to 898. In addition, FDA may
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898 may be found in the Code of Peachar Ingerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that IDA's issualice of a backers on the other requirements of the Act
that FDA has made a determination that your device complies with other must that FDA has made a decernmanon that Jour access as agencies. You must of of any Federal statutes and regulations as including, but not limited to: registration and listing comply with all the Act 3 requirements, meaths, good manufacturing practice requirements as set
(21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing the ologtrop (2) CFR Part 807); labelling (21 CFR Part 820); good art 820); and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Party 11 CFR 1000 1050 forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2- Mr. Jay Mansour
This letter will allow you to begin marketing your device as described in your Section 510(k) I his letter will anow you to begin marketing of substantial equivalence of your device to a legally premarket nothication. The PDA miding of bassification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
s antiled If you desire specific advice for your don'ter at (301) 827-8910. Also, please note the regulation entitled,
contact the Office of Compliance at (301) 827-8910. Also, pleas contact the Office of Complance at (501) 627 627 627 67 67 807.97). You may obtain " Misbranding by relectice to premance notifical varies and er the Act from the Division of Small other general Information on your responsible and its toll-free number (800) 638-2041 or Manufacturers, International and Oolisanter : 15566777 or and industry/support/index.html.
Sincerely yours,
David M. Whipple
David M. Whipple Acting Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) Number (if known): K050807
Device Name: Laser/Illumination/Aspiration/Back-wash probe, LF100
Indications For Use:
For use to perform endo-ocular laser photocoaguation treatments, with illumination,
the sub-For use to perform endo-ocular laser photocoaguation area.home, while havelength is 500nm
aspiration and back-wash during surgical interventions. The operating wavelength is to 1,100nm.
V Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use __ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
C. C. Claussen
(Division Sign-Off)
Division of Ophthalmic Ear
Division of Ophthalmic Ear, Nose and Throat Devises
K050807 510(k) Number _
Page 1 of ____________________________________________________________________________________________________________________________________________________________________